Product
Intensive treatment
Aliases
Poor response to previous biologic therapy
1 clinical trial
1 indication
Indication
PsoriasisClinical trial
A Multicenter, Open-label Study to Evaluate the Efficacy and Safety of IBI112 in Participants With Psoriasis Who Were Treated With Biologics and Switched to IBI112Status: Recruiting, Estimated PCD: 2024-09-30